Safety Alerts

Medicine Supply Notification: Rivastigmine 4.6mg/24hours and 9.5mg/24hours transdermal patches – updated

Published
Source
PSNC Dispensing & Supply News
Imported
6 Jun 2026

Update 04/06/2026: Changes in the alert below are in bold Update 08/01/2026: Alzest transdermal patches (Dr Reddy’s Laboratories (UK) Ltd) in all strengths have been discontinued. Please note: Care is needed if switching between daily and twice weekly (Zeyzelf) rivastigmine patches to avoid the risk of dosing error. The Department of Health and Social Care (DHSC) [...]

The post Medicine Supply Notification: Rivastigmine 4.6mg/24hours and 9.5mg/24hours transdermal patches – updated appeared first on Community Pharmacy England.

View original alert (opens in a new tab)

Important: This alert is gathered automatically for information only. Always refer to the original source and follow your practice’s own clinical governance procedures.

The weekly digest lists every alert published in a week, grouped by source. View the weekly digest

Back to Safety Alerts